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MATERIALS AND METHODS
washed with phosphate-buffered saline (PBS) and maintained at 37°C in culture medium in the 117 absence of serum and trypsin IX, unless differently specified. For multi-step virus growth curves, 118 infected cells (0.01 PFU/cell) were incubated in the same medium containing 1 μg/ml trypsin-IX.
119
Virus yield was determined after three cycles of freezing-thawing of infected cultures, by 120 hemagglutinin titration (SA11) or infectivity assay (Wa), according to standard procedures 121 (13,14). EC 50 (effective concentration 50%) and CC 50 (cytotoxic concentration 50%) were 122 calculated using Prism 5.0 software (GraphPad Software Inc., San Diego, CA). In the case of 123 SA11 virus, similar results (nitazoxanide EC 50 = 1 μg/ml in MA104 cells) were obtained by using 124 hemagglutinin titration or infectivity assay; hemagglutinin titrations were then used for this 125 virus. Microscopical examination of rotavirus-induced cytopathic effect was performed using
126
Leica DM-IL microscope. Images were captured on Leica DC-300 camera using Image-
127
Manager500 software (Leica Microsystems-GmbH, Wetzlar, Germany). lysates were subjected to centrifugation at 16,000 x g for 10 min to remove cellular debris.
154
Supernatants were then subjected to ultracentrifugation at 180,000 x g (Beckman XL-100K Olympus Plan-Apochromat 60× oil-immersion objective. Images (800 × 800 pixels resolution)
199
were analyzed using Imaris 6.2 software (Bitplane, Zurich, CH). To determine the average size
200
of viroplasms, the area (μm 2 ) was measured on at least 400 viroplasms for each sample using Cytoprotective and antiviral activity of thiazolides in in-vitro rotavirus infection.
250
The antiviral activity of nitazoxanide and tizoxanide was evaluated in vitro against two different Figure 1A ).
258
Nitazoxanide treatment caused a dose-dependent inhibition of virus replication with EC 50 of 1 259 μg/ml and 2 μg/ml for SA11-and Wa-viruses respectively ( Figure 1D ,E). Tizoxanide was more 260 active than NTZ against both the simian (EC 50 = 0.5 μg/ml) and human (EC 50 = 1 μg/ml) viruses
261
( Figure 1D ,E). Both drugs were effective at concentrations non-cytotoxic for uninfected cells
262
(CC 50 > 50 μg/ml), as determined by MTT assay in mock-infected cells at 24h p.i..
263
Thiazolides antiviral activity was independent of the multiplicity of infection. SA11-virus effective, but still able to inhibit virus replication, whereas the drug lost its effect when 287 administered at 12h p.i..
288
To investigate whether thiazolides affect virus protein synthesis, mock-infected or SA11-infected
289
(5 PFU/cell) MA104 cells were treated with 10 μg/ml TIZ after virus adsorption and, at 3h p.i., in particular levels of the outer-layer VP4 and VP7 proteins were found to be greatly decreased.
303
A significant reduction in the yield of triple-layered particles (TLP) was confirmed following
304
CsCl gradient purification of viral particles from TIZ-treated cells ( Figure 4D ).
305
These results suggest that thiazolides are not affecting viral protein synthesis, but may interfere 306 with viral particles morphogenesis. confocal microscopy using FluoView-1000 software. The viroplasm average area was found to 317 be highly reduced in TIZ-treated samples as compared to control ( Figure 5C ).
318
In order to determine the effect of thiazolides on the number of viroplasms per cell, and to shown in Figure 6A ,B, confirmed that thiazolide treatment caused a significant reduction in the 326 number of viroplasms per cell, and greatly reduced the total viroplasm area in infected cells. promoter. After 6h, transfected cells were treated with 10 μg/ml TIZ or vehicle and, after 18h,
367
VLS were visualized by confocal microscopy using FluoView-1000 software. As shown in individuals.
394
The results described herein document the anti-rotaviral activity of nitazoxanide and its active 395 circulating metabolite tizoxanide. The mechanism of antiviral action appears to be novel. Therefore, the observed reduction in viroplasm size under treatment with thiazolides may reflect 409 a compromised viroplasm assembly.
410
The mechanism responsible for the impaired NSP2/NSP5 interaction remains to be established.
411
A defect in NSP5 oligomerization was detected in thiazolide-treated cells (S. La Frazia and M.G. proposed as a drug target (33).
441
In the case of viral infections, the fact that, in addition to rotavirus, nitazoxanide also inhibits the 
